Are Cyclin-dependent Kinase 4/6 Inhibitors Needed for all Oestrogen Receptor-positive Metastatic Breast Cancers?
Collections
Research team
Endocrine Therapy Resistance
Language
eng
Date accepted
2017-06-19
License start date
2017-11
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (11), pp. 703 - 706